Outset Medical, Inc.
OM
$4.21
-$0.09-2.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 13.54% | -3.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.54% | -3.50% | |||
| Cost of Revenue | 16.39% | -5.26% | |||
| Gross Profit | 9.81% | -1.11% | |||
| SG&A Expenses | 0.48% | -5.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.65% | -3.70% | |||
| Operating Income | 7.35% | 4.03% | |||
| Income Before Tax | 5.31% | 3.27% | |||
| Income Tax Expenses | 1.38% | 128.42% | |||
| Earnings from Continuing Operations | 5.24% | 2.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.24% | 2.63% | |||
| EBIT | 7.35% | 4.03% | |||
| EBITDA | 6.67% | 3.73% | |||
| EPS Basic | 6.49% | 5.59% | |||
| Normalized Basic EPS | 6.57% | 6.20% | |||
| EPS Diluted | 6.49% | 5.59% | |||
| Normalized Diluted EPS | 6.57% | 6.20% | |||
| Average Basic Shares Outstanding | 1.34% | 3.12% | |||
| Average Diluted Shares Outstanding | 1.34% | 3.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||